Vaccine injury compensation bill
Executive SummaryMeasure sponsored by Rep. Waxman (D-Calif.) is expected to be considered by House Ways & Means Committee Oct. 14 or 15. The late review of the bill by the panel, which will consider the measure's tax implications, further reduces chances for passage. An additional impediment to enactment could be presented by the Administration, which reportedly is concerned that the bill's compensation mechanism presents constitutionality concerns regarding separation of powers. The Senate Judiciary Committee is said to have asked for a review those provisions.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.